mirtazapine has been researched along with Migraine Disorders in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
Excerpt | Relevance | Reference |
---|---|---|
"Mirtazapine was then initiated for residual depressive symptoms." | 2.71 | Migraine headache prophylaxis and treatment with low-dose mirtazapine. ( Lévy, E; Margolese, HC, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lévy, E | 1 |
Margolese, HC | 1 |
1 trial available for mirtazapine and Migraine Disorders
Article | Year |
---|---|
Migraine headache prophylaxis and treatment with low-dose mirtazapine.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Humans; Mianserin; Migraine Di | 2003 |